Accrol Group Holdings PLC (LON:ACRL), the AIM listed leading independent tissue converter, has celebrated the official opening of its new 168,000 sq ft manufacturing facility in Leyland.
The new facility has had two tissue converting lines installed, which will increase Accrol’s total converting capacity to 143,000 tonnes per annum.
Manufacturing began at the end of January and output will steadily increase as new shift patterns are added over the coming weeks.
When both lines are fully manned they will create over 80 new jobs. That will take Accrol’s total number of employees to almost 600, all of whom are based in Lancashire. The new facility has space for a further four converting lines.
Steve Crossley, Accrol’s CEO, said: This new facility marks another milestone in Accrol’s development, increasing our total production capacity by 25,000 tonnes to 143,000 tonnes per annum.